Affiliation:
1. Department of Applied Mathematics and Statistics, University of Maryland Baltimore County, USA
2. Department of Mathematics, Howard University, USA
Abstract
<abstract><p>A model with both casual and long-term partnerships is considered with respect to the impact of a pre-exposure prophylaxis (PrEP) on the spread of HIV. We consider the effect of the effectiveness of PrEP, the rate that susceptible individuals choose to take PrEP, and compliance with the daily dose of the pre-exposure prophylaxis. The rate of infection in long-term partnerships is computed using a linearized expected value as a means for including the nonlocal effects of long-term partnerships while maintaining computational feasibility. The reproduction numbers for models with casual partnerships, long-term partnerships, and a combination of both are analytically computed and global stability of both disease-free and endemic equilibria is shown. Sensitivity and PRCC analysis results suggest that increasing the compliance among the current PrEP users is a more effective strategy in the fight against the HIV epidemic than increased coverage with poor compliance. Furthermore, an analysis of the reproduction number shows that models with either casual or monogamous long-term partnerships can reach the desired $ R_0 < 1 $ threshold for high enough levels of compliance and uptake, however, a model with both casual and monogamous long-term partnerships will require additional interventions. Methods highlighted in this manuscript are applicable to other incurable diseases or diseases with imperfect vaccines effected by long-term partnerships.</p></abstract>
Publisher
American Institute of Mathematical Sciences (AIMS)
Subject
Applied Mathematics,Computational Mathematics,General Agricultural and Biological Sciences,Modeling and Simulation,General Medicine
Reference34 articles.
1. CDC, HIV in the United States and dependent areas, 2019. Available from: https://www.cdc.gov/hiv/statistics/overview/ataglance.html.
2. B. T. Foley, B. T. M. Korber, T. K. Leitner, C. Apetrei, B. Hahn, I. Mizrachi, et al., HIV Sequence Compendium 2018, United States: N. p., 2018. https://doi.org/10.2172/1458915
3. A. S. Fauci, R. R. Redfield, G. Sigounas, M. D. Weahkee, B. P. Giroir, Ending the HIV epidemic: a plan for the United States, JAMA, 321 (2019), 844–845. https://doi.org/10.1001/jama.2019.1343
4. CDC, Preexposure prophylaxis for the prevention of HIV infection in the United States - 2017 update: a clinical practice guideline, 2018. Available from: https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf.
5. J. Franks, Y. Hirsch-Moverman, A. S. Loquere, K. R. Amico, R. M. Grant, B. J. Dye, et al., Sex, PrEP, and stigma: experiences with HIV pre-exposure prophylaxis among New York City MSM participating in the HPTN 067/ADAPT study, AIDS Behav., 22 (2018), 1139–1149. https://doi.org/10.1007/s10461-017-1964-6
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献